
Profitability, historical returns, and peer comparisons.
According to BioMarin Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current ROE is 1.18%. This represents a change of 317.19% compared to the average of 0.28% of the last 4 quarters.
The mean historical ROE of BioMarin Pharmaceutical Inc. over the last ten years is 0.87%. The current 1.18% ROE has changed 35.64% with respect to the historical average. Over the past ten years (40 quarters), BMRN's ROE was at its highest in in the September 2020 quarter at 19.36%. The ROE was at its lowest in in the December 2016 quarter at -2.85%.
Average
0.87%
Median
1.16%
Minimum
-22.78%
Maximum
20.80%
Discovering the peaks and valleys of BioMarin Pharmaceutical Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 218.37%
Maximum Annual ROE = 20.80%
Minimum Annual Increase = -2823.25%
Minimum Annual ROE = -22.78%
| Year | ROE | Change |
|---|---|---|
| 2025 | 5.73% | -24.02% |
| 2024 | 7.54% | 122.83% |
| 2023 | 3.39% | 10.09% |
| 2022 | 3.08% | -304.72% |
| 2021 | -1.50% | -107.22% |
| 2020 | 20.80% | -2823.25% |
| 2019 | -0.76% | -70.64% |
| 2018 | -2.60% | -37.57% |
| 2017 | -4.17% | -81.71% |
| 2016 | -22.78% | 218.37% |
The current ROE of BioMarin Pharmaceutical Inc. (BMRN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.55%
5-year avg
3.65%
10-year avg
0.87%
BioMarin Pharmaceutical Inc.’s ROE is less than Ultragenyx Pharmaceutical Inc. (392.35%), greater than Ionis Pharmaceuticals, Inc. (-110.84%), less than BridgeBio Pharma, Inc. (26.76%), less than PTC Therapeutics, Inc. (57.10%), greater than Travere Therapeutics, Inc. (-55.79%), less than Ascendis Pharma A/S (190.44%), less than Pharming Group N.V. (8.96%), less than Alnylam Pharmaceuticals, Inc. (159.72%), less than Vertex Pharmaceuticals Incorporated (23.31%), greater than Insmed Incorporated (-82.75%),
| Company | ROE | Market cap |
|---|---|---|
| 392.35% | $1.59B | |
| -110.84% | $7.05B | |
| 26.76% | $14.87B | |
| 57.10% | $5.03B | |
| -55.79% | $4.69B | |
| 190.44% | $16.51B | |
| 8.96% | $888.60M | |
| 159.72% | $21.16B | |
| 23.31% | $143.40B | |
| -82.75% | $24.21B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioMarin Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioMarin Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioMarin Pharmaceutical Inc.'s ROE?
How is the ROE calculated for BioMarin Pharmaceutical Inc. (BMRN)?
What is the highest ROE for BioMarin Pharmaceutical Inc. (BMRN)?
What is the 3-year average ROE for BioMarin Pharmaceutical Inc. (BMRN)?
What is the 5-year average ROE for BioMarin Pharmaceutical Inc. (BMRN)?
How does the current ROE for BioMarin Pharmaceutical Inc. (BMRN) compare to its historical average?